# Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)

> **NCT05307237** · NA · COMPLETED · sponsor: **Scripps Whittier Diabetes Institute** · enrollment: 518 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Dexcom G6 Continous Glucose Monitoring Management
- **DEVICE:** Usual Care - Blinded Continuous Glucose Monitoring Management

## Key facts

- **NCT ID:** NCT05307237
- **Lead sponsor:** Scripps Whittier Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-19
- **Primary completion:** 2025-12-17
- **Final completion:** 2025-12-17
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307237, "Continuous Glucose Monitoring for High-Risk Type 2 Diabetes in the Hospital (Cyber GEMS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05307237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*